MJP
Michael J. Puzo Portfolio holdings
AUM
$351M
This Quarter Return
+2.95%
1 Year Return
+12.34%
3 Year Return
+65.3%
5 Year Return
+106.55%
10 Year Return
+254.06%
AUM
$360M
AUM Growth
+$360M
(-0.13%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
3.21%
Top 10 Holdings %
Top 10 Hldgs %
41.32%
Holding
75
New
–
Increased
14
Reduced
48
Closed
2
Top Buys
| 1 |
NVIDIA
NVDA
|
$15.8M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$2.32M |
| 3 |
Carrier Global
CARR
|
$2.18M |
| 4 |
McCormick & Company Non-Voting
MKC
|
$1.7M |
| 5 |
Ball Corp
BALL
|
$1.69M |
Top Sells
| 1 |
Nike
NKE
|
$3.16M |
| 2 |
Novartis
NVS
|
$2.31M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$910K |
| 4 |
Advanced Micro Devices
AMD
|
$681K |
| 5 |
Fiserv
FI
|
$631K |
Sector Composition
| 1 | Technology | 29.59% |
| 2 | Healthcare | 20.43% |
| 3 | Industrials | 12.86% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Financials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ecolab
ECL
$78.6B
| $458K | 0.13% |
1,925
-300
| -13% | -$71.4K |
|
52
Adobe
ADBE
$151B
| $439K | 0.12% |
791
+154
| +24% | +$85.6K |
|
|
53
Nike
NKE
$114B
| $370K | 0.1% |
4,910
-41,935
| -90% | -$3.16M |
|
54
Sysco
SYY
$38.5B
| $369K | 0.1% |
5,170
-845
| -14% | -$60.3K |
|
55
Dover
DOV
$24.5B
| $361K | 0.1% |
2,000
-200
| -9% | -$36.1K |
|
|
56
Alphabet (Google) Class C
GOOG
$2.58T
| $334K | 0.09% |
1,820
| – | – |
|
57
Honeywell
HON
$139B
| $330K | 0.09% |
1,544
-110
| -7% | -$23.5K |
|
58
American Express
AXP
$231B
| $324K | 0.09% |
1,400
-100
| -7% | -$23.2K |
|
59
Bank OZK
OZK
$5.91B
| $320K | 0.09% |
7,815
-860
| -10% | -$35.3K |
|
60
Wells Fargo
WFC
$263B
| $297K | 0.08% |
5,000
| – | – |
|
61
Bank of Montreal
BMO
$86.7B
| $293K | 0.08% |
3,500
| – | – |
|
62
Texas Instruments
TXN
$184B
| $292K | 0.08% |
1,500
-150
| -9% | -$29.2K |
|
63
Nucor
NUE
$34.1B
| $285K | 0.08% |
1,800
| – | – |
|
64
Coca-Cola
KO
$297B
| $255K | 0.07% |
4,000
| – | – |
|
65
Paychex
PAYX
$50.2B
| $237K | 0.07% |
2,000
-300
| -13% | -$35.6K |
|
66
Bristol-Myers Squibb
BMY
$96B
| $220K | 0.06% |
5,300
-800
| -13% | -$33.2K |
|
67
Idexx Laboratories
IDXX
$51.8B
| – | – |
-400
| Closed | -$216K |
|
68
Edwards Lifesciences
EW
$47.8B
| – | – |
-3,350
| Closed | -$320K |
|